BIOGRAPHICAL SKETCH · Prof. Serge Rudaz

Biomedical and Metabolomics Analysis
School of Pharmaceutical Sciences
Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO)
University of Geneva, Switzerland

Serge Rudaz studied pharmacy in Switzerland, where he obtained his PhD in 1997. Later, he joined the National Research Center in Roma (Italy) for a post-doctoral position concerning the application of capillary electrophoresis (CE) hyphenated to mass spectrometry (MS) for chiral separation in biological fluids. He was promoted to Associate Professor in 2012 at the School of Pharmaceutical Sciences, University of Geneva, where he leads the biomedical and metabolomics analysis (BMA) group. He is a member of several scientific societies and scientific boards.
In addition to acting as a research group leader and member of the management board of the Swiss Centre for Applied Human Toxicology (SCAHT) Foundation, he is also President of the Swiss Metabolomics Society (SMS) and vice-president of the Competence Center in Chemical and Toxicological Analysis (ccCTA).
Currently, he is interested in (UHP)LC, SFC and CE coupled to MS, advances in sample preparation, analysis of pharmaceuticals and falsified medicines, biological matrices, and clinical and preclinical studies, which include metabolism and toxicological analysis. Serge Rudaz is an expert in a variety of chemometric approaches, including experimental design (DOE) validation and regulation (ISO17025), as well as multivariate data analysis (MVA). He is a (co)author of over 20 book chapters and 320 peer-reviewed papers, with an H-index (Scopus) of 54. He was chair/co-chair of several national or international congress, such as Chimiométrie 2015, SEP 2017 and MSB 2012 and 2020.